Multiple sclerosis (MS) is an autoimmune disease ... the authors set out to investigate the therapeutic potential of LINGO1 inhibition in demyelinating diseases using mice with myelin ...

The treatment of multiple sclerosis (MS ... transmembrane peptides targeting a novel mechanism of action promoting remyelination. Current immunomodulatory approaches have failed to stop MS ...

A visual evoked potential (VEP) test is one test that a doctor may use to diagnose multiple sclerosis and monitor disease treatment and progression. Your brain and spinal cord make up your central ...

The small molecule therapeutic is designed to promote remyelination in neurological diseases, including multiple sclerosis (MS). PTD802 is a selective GPR17 antagonist developed under an exclusive ...